Sofosbuvir and Daclatasvir in Mono- and HIV-coinfected Patients with Recurrent Hepatitis C After Liver Transplant

Sofosbuvir and Daclatasvir in Mono- and HIV-coinfected Patients with Recurrent Hepatitis C After Liver Transplant

Background and aims: Pegylated interferon (Peg-INF) and ribavirin (RBV) based therapy is suboptimal and poorly tolerated. We evaluated the safety, tolerability and efficacy of a 24-week course of sofosbuvir plus daclatasvir without ribavirin for the treatment of hepatitis C virus (HCV) recurrence af...

Full description

Bibliographic Details
Main Authors: Lluís Castells, Jordi Llaneras, Isabel Campos-Varela, Itxarone Bilbao, Manel Crespo, Oscar Len, Francisco Rodríguez-Frías, Ramon Charco, Teresa Salcedo, Juan Ignacio Esteban, Rafael Esteban-Mur
Format: Article
Language:English
Published: Elsevier 2017-01-01
Series:Annals of Hepatology
Subjects:
Direct-acting antivirals
Drug-drug interactions
Liver transplant and sustained virological response
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119303655

Internet

http://www.sciencedirect.com/science/article/pii/S1665268119303655

Similar Items